COVID-19: Janssen Limits, Vaccines Linked to Medicare Savings
May 10, 2022 ||FDA limits authorized use of the Janssen COVID-19 vaccine after reports of thrombosis with thrombocytopenia syndrome following vaccination; a new analysis estimates vaccines are associated with $2.6 million in savings due to a reduction in Medicare hospitalizations.
view more »